NANOBIOTIX : Nanobiotix expands its clinical development in Head and Neck cancer and Immuno-Oncology ; new ... - GlobeNewswire (press release)

NANOBIOTIX : Nanobiotix expands its clinical development in Head and Neck cancer and Immuno-Oncology ; new ... GlobeNewswire (press release) Presentation of the Phase I/II data of Nanobiotix's European head and neck trial with NBTXR3 at the American Society of Clinical Oncology (ASCO) Annual Meeting in June. Nanobiotix is preparing the next clinical trials of the head and neck cancer program. and more »

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2owNUTt
via IFTTT